BridgeBio Pharma Inc

Market cap: $4,940,866,162

Exchange: NAS

Sector: Health Technology

BridgeBio Pharma, Inc. is a pharma company. The firm engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly and Neil Kumar on May 17, 2019 and is headquartered in Palo Alto, CA.

STOCK PRICE CHART

Key Statistics

Company Name

BridgeBio Pharma Inc

Average Volume (10 days)

1,529,319

Average Volume (30 days)

1,623,150

Moving Average (50 days)

$30.74

Moving Average (200 days)

$31.59

Ex-Divided Date

n/a

Dividend Yield

P/E Ratio

-7.6817

Market Cap

4,940,866,162

Shares Outstanding

175,831,536

52-Week High Split Adjust Only

44.32

52-Week Low Split Adjust Only

12.75

Employee Count

333

Beta

2.0175

Next Earnings Date

2024-05-02

TTM Dividend Rate Per Share

Price Changes

Past 5 days

-0.09%

Past 30 days

-0.05%

Past 3 months

-0.25%

Past 6 months

0.14%

Past year

0.81%

Past 2 years

1.32%

Past 5 years

0.02%

Max % Change

0.02%

PEER GROUP COMPARATIVE PERFORMANCE

Name	Ticker	Price/Sales (ttm)	Price/Book (ttm)	Forward P/E	PEG Ratio	EV/Revenue
BridgeBio Pharma Inc	BBIO	n/a	n/a	-15.3	n/a	n/a
Peer Avg	N/A	n/a	n/a	n/a	n/a	n/a
Onconova Therapeutics Inc	ONTX	n/a	n/a	n/a	n/a	n/a